Interestingly, immune activation has been shown to increase the production of amyloid-β and the hyperphosphorylation of tau proteins [26] and seems to precede the deposition of amyloid-β plaques [27], which supports the hypothesis that inflammation is a causal factor in AD development (for review, see [28]). This evidence concerns the gene MAPT and Alzheimer disease.